Please login to the form below
Nuclear medicine
This page shows the latest Nuclear medicine news and features for those working in and with pharma, biotech and healthcare.
Coronavirus disruption scuppers Curium Pharma sale
The impact of coronavirus on the economy took another turn this week after CapVest shelved its sale of nuclear medicine specialist Curium Pharma, blaming the outbreak. ... Paris-headquartered Curium was formed three years ago via the merger of
Latest news
-
Novartis buys cancer specialist Endocyte for $2.1bn
Acquisition includes 'universal' CAR-T platform. Novartis has agreed another bolt-on deal to boost its pipeline, buying nuclear medicine firm Endocyte for $2.1bn as it raised its sales forecasts
-
AAA’s orphan drug Lutathera wins EU green light
Numerous clinical studies in the nuclear medicine field have demonstrated the advantages of selectively delivering radiation to tumour cells over certain therapies, and we are committed to advancing this approach to
-
Norgine moves to raise awareness of head and neck cancer procedure
The partners also intend to highlight the importance of nuclear medicine as a critical part of the multi-disciplinary team.
-
Ireland’s Mallinckrodt makes $1.3bn immunotherapy purchase
With this expansion into immunotherapy we add to our footprint of nuclear medicine, pain management, and respiratory neonatal critical care, broadening our touch points in hospitals and further expanding our portfolio
-
New accounts: March
Pre-launch. Pre-launch. Discovery London. GE Healthcare. New product. Nuclear medicine. Lowe Fusion. ... GE Healthcare. Steripet. Nuclear medicine. Lowe Fusion. GSK/Roche. Bonviva. Osteoporosis. Virgo Health PR.
More from news
Approximately 1 fully matching, plus 6 partially matching documents found.
Latest Intelligence
-
Deal Watch August 2016
Pharmaceutical companies are expanding into other non-medicine technologies in addition to digital technology. ... Mallinckrodt (US) Nuclear Imaging business. IBA Molecular (BE). Asset acquisition. Diagnostic imaging products for use in nuclear medicine
-
Deal Watch March 2016
Portfolio of diagnostic equipment including X-ray, MRI, Ultrasound and Nuclear Medicine systems.
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
After a busy first quarter, emotive welcomes five new team members
Fiona has a BSc in Medical Physics which involved studying subjects such as Radiotherapy, Nuclear Medicine and Medical Imaging techniques and wrote her dissertation in Ultrasound diagnostics.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- BMS and Janssen’s antithrombotic granted FDA fast track designation
- Sanofi's frexalimab shows promise in relapsing forms of MS
- Amgen reports positive results for Otezla in psoriatic arthritis
- EMA recommends revoking marketing authorisation for Novartis’ sickle cell disease drug
- Seqera Labs and Genomics England partner to progress genomic research
- Pfizer’s antibiotic combination shows promise in treating multi-drug resistant infections
- Supporting the most vulnerable: why pharma should get behind the NHS’ healthcare equity campaign
- Healing the Healers
- The (inevitable) digital transformation of Medical Affairs
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- Pfizer’s RSV vaccine approved by FDA for older adults
No results were found
PMHub
Oncosec
OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...
Latest intelligence
- Healing the Healers
- Because if we do not heal the healers, who is going to heal us?...
- The (inevitable) digital transformation of Medical Affairs
- It’s not a question of ‘if,’ it’s a question of ‘when.’...
- Oncology eBook: Reducing the care gap in cancer prevention, diagnosis, and treatment
- Despite significant innovation in the oncology landscape, there is a growing care gap preventing patients accessing and benefiting from innovations in cancer treatment. In this new publication, our oncology experts...
